No­var­tis, Mo­men­ta grab a de­layed FDA OK for block­buster Co­pax­one knock­off

Af­ter a long de­lay, Mo­men­ta $MN­TA and No­var­tis $NVS have fi­nal­ly re­ceived an FDA green light for its Co­pax­one copy­cat, catch­ing up with My­lan in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.